Materials and Methods
Patients and Cell Samples. All 12 patients exhibited peripheral blood and bone marrow infiltration by cells displaying characteristic LGL morphology, i.e., abundant moderately basophilic cytoplasm, numerous azurophilic granules, round nuclei, and absent nucleoli.
LGL were isolated from 12 patients with T3, LPD by Ficoil-Hypaque density gradient centrifugation of freshly drawn heparinized peripheral blood, followed by depletion of adherent monocytes on plastic. Normal LGL were obtained from healthy donors as described by Timonen and Saksela (7) on a discontinuous 35-47.5% gradient of Percoll (Pharmacia, Inc., Uppsala, Sweden), with minor modification.
Monoclonal Antibody-defined Cell Surface Markers and Morphology. The membrane phenotype of the isolated cells was determined by indirect immunofluorescence using a Zeiss microscope and/or a FACS IV (Becton Dickinson Immunocytometry Systems, Mountain View, CA). The following panel of monoclonai antibodies was used: OKT3, OKT6, OKT8, OKT 11, and OKM 1 (Ortho Diagnostic Systems Inc., Raritan, NJ or gifts of Dr. E. Reinherz, Dana-Farber Cancer Institute, Boston, MA); HNK-1 (8), reactive with NK cells and a subset of T cells (courtesy of Dr. T. Abo, University of Alabama, Birmingham, AL); B73.1 (2) (courtesy of Dr. G. Trinchieri, Philadelphia, PA) and AB8.28 (9) (courtesy of Dr. Malavasi, University of Torino, Torino, Italy), both reactive with a structure closely associated with the Fc"r receptor of LGL; N901, reactive with LGL and some myeloid precursors (10) (courtesy of Dr. J. Griffin, Dana-Farber Cancer Institute, Boston, MA).
Cytotoxicity Assays. NK activity was assessed by using the K562 cell line at effector/ target cell (E/T) ratios of 25:1 to 100:1, in a 4 h 5~Cr-release assay, as previously described (11) . For ADCC, S~Cr-labeled TLX9 murine lymphoma cells, sensitized with 1:10,000 rabbit antibody, were used as targets in a 4 h test (12) .
In a series of experiments, effector cells (2 × 106/ml in RPMI 1640 medium with 10% pooled human serum) were cultured for 72 h with IL-2. Supernatant of the gibbon lymphosarcoma line MLA 144 (50% final concentration, 100 U/mi) (13) or recombinant IL-2 (100 #g/ml) (a gift of Dr. J. Schindler, Biogen Research Corp., Cambridge, MA) were the I L-2 sources. Cytotoxicity was assessed against K562 cells or against the relatively NK-resistant Daudi line. We will refer to IL-2-induced cytotoxicity as lymphokineactivated killer (LAK) function, as suggested by others (14) . Results are presented as the percentage of specific lysis (mean + SD, three replicates per group) after subtraction of spontaneous release in the absence of effectors. 4-6% differences above background were statistically significant.
DNA Extraction and Southern Blot Analysis. DNA was prepared by cell lysis, proteinase K digestion, extraction with phenol, and precipitation with ethanol (15) . 15 #g of DNA were digested with the appropriate restriction endonuclease, electrophoresed in a 0.8% agarose gel, denatured, neutralized, transferred to a nitrocellulose filter, and hybridized according to Southern (15) . Filters were washed in 0.2 × SSC, 0.5 sodium dodecyl sulfate (SDS), pH 7 at 60°C for 2 h.
DNA Probes. The TB probe was derived from a human cDNA T~8 clone (YTJ-2) isolated from the Jurkat-2 T lymphoma cell line (courtesy of Dr. Tak Mak) (5). This clone hybridizes to both alleles (C0~ and C02) of the constant region and to one or more alleles of the variable regions (5, 16) . The generation of fragments specific for the constant (T¢~C) region have been previously described (16) . DNA fragments were s2P-labeled by nick translation for use as probes (15) . Table I summarizes the principal immunophenotypic and functional properties of the LGL isolated from each of the 12 cases of T~ LPD. In each case, the LGL expressed the T 11 sheep erythrocyte receptor, the NK cell surface marker HNK-1, and Fc~ receptors identified by rosetting techniques (data not shown), by AB8.28 or by B73.1 monoclonal antibodies, and by ADCC effector function. Table I . DNA were digested with the indicated restriction enzymes and hybridized to a T/3 probe representative of the constant region of the TI3 gene (TBC).
Results
Surface markers T3, T 8 , OKM1, and N901 were detected in the LGL isolated from some but not all cases. All L G L were negative for T6.
LGL from all T'y LPD patients had high ADCC, whereas high NK activity was only detected in cases 2, 4, and 11. L G L from T3, LPD (except patient 9), on cultivation in the presence of IL-2 for 72 h, developed high lytic activity against both K562 and the more resistant Daudi cells. L G L cultured in medium alone showed some enhancement of lytic activity (up to 40% specific lysis against K562) in one case (No. 12). We analyzed the organization of TI3C by Southern blot hybridization using Eco RI or Bam HI restriction enzymes, and a TBC probe. Results are summarized in Table I and illustrated in Fig. 1 . T h e cells isolated from nine cases exhibited bi-allelic deletion of the Eco RI 12.0 kb DNA fragment, a pattern we have previously shown to be characteristic of both polyclonal and monoclonal immature and mature T cell populations (16) . Clonal rearrangements of the TI3C gene were demonstrated in five of these nine cases, indicated by the presence of new hybridization bands that were not detectable in control DNA (see bands marked by arrow in cases 3, 4, 7, and 10 in Fig. 1 ). In the remaining four cases (Nos. 5, 9, 11, and 12), clonal rearrangements were found when the extracted DNA were digested with Barn HI, thus demonstrating the monoclonal nature of all nine cases of T3' LPD. T h e L G L isolated from the three remaining cases (Nos. 1, 2, and 6) displayed the germline Eco RI band pattern. However, Bam HI digestion demonstrated the presence of clonally rearranged bands in case 6. T h e remaining two cases (Nos. 1 and 2) displayed an intact germline TI3C locus upon digestion with Eco RI, Bam HI (see Fig. 1 ), and Hind III (not shown). It is noteworthy that these two T/3 g e n e -u n r e a r r a n g e d cases did not appreciably express the T 3 antigen (Table I) . We conclude that T3' LPD are heterogeneous in the organi-T/3 GENE REARRANGEMENTS IN LGL/NK PROLIFERATIONS zation of the T/3 gene. The more frequently encountered cases of T3 + T3' LPD show clonal rearrangements (T3÷T/3 + T'y LPD), whereas the less common T3-T3' LPD exhibit the germline T/3 configuration (T3-T/3-Ty LPD).
Discussion
Our results appear to divide the 12 cases of Ty LPD into two distinct groups, based on their expression of the T3 antigen and on rearrangements of the T~ gene. Both T3+T~ + and T3-T~= T'r LPD usually expressed and, in most instances, coexpressed, the T cell-restricted antigens T ll and T8 and the myeloid-associated antigent Mol. Most notably, an analogous pattern was found in clonal NK populations derived from normal cells; i.e., both T3+T~+T~ + and T3-T~-Ta-NK clones exist and both groups are heterogeneous in the expression of the T8 and Mol antigens (18, 19) . These observations indicate that the immunogenotypic and immunophenotypic heterogeneity of these Ty LPD cases is not due to lineage infidelity, a phenomenon occasionally observed in hematopoietic tumors. Conversely, these neoplastic cases suggest the existence of two normal NK subpopulations that (a) are distinguishable by the presence of T~ gene rearrangements and T3 antigen expression, and (b) express T8 and Mol antigens.
The existence of two LGL/NK subpopulations can be explained by at least two possibilities. First, they may reflect two separate differentiation lineages. For example, T3+T~ + NK clones and tumors may represent proliferations of peripheral T cells displaying NK-like phenotype, morphology, and functions, while T3-T~-cells may belong to a non-T cell-related lineage. Alternatively, a common differentiation pathway may exist in which, together with the appearance (or disappearance) of various lymphoid or myelomonocytic markers (e.g., T8 and Mol antigen), LGL/NK cells can acquire the ability to express the T3/T cell antigen receptor complex. This latter possibility is supported by recent studies from our laboratories (Pelicci, manuscript submitted for publication) showing that peripheral blood LGL/NK cells do not express the T3 antigen, do contain a germline T~ gene, and do not express T~ or To~ mRNA. However, T~ gene rearrangements and expression, accompanied by Ta gene and T3 antigen expression, can be induced in vitro in a T8 + LGL/NK cell subset upon cultivation with IL-2. These findings suggest the existence of an IL-2-dependent LGL/NK differentiation pathway that appears to be clearly distinct from the conventionally defined T cell lineage, based on a number of features including: (a) its thymus independence, (b) the expression of specific LGL markers, and (c) the coexpression of T8 and Mol antigens. We propose that LGL isolated from patients with Ty LPD may represent expansions of cells blocked at different stages of differentiation/activation within the LGL/NK hematopoietic lineage(s).
The often chronic, noninvasive clinical behavior of Ty LPD has led to the hypothesis that it represents a reactive rather than a neoplastic process (20) .
However, our studies demonstrate that the cellular expansion is monoclonal in origin, at least in the Ty LPD cases displaying T~ gene rearrangements. It is intriguing that the majority of cases of T'r LPD are TS+T3 + when the majority of peripheral blood normal LGL/NK cells are T~8-T 3-. The latter finding suggests that a presumably more differentiated/activated target is frequently involved in T3, LPD.
Summary
Twelve cases of T3' LPD (lymphoproliferative disorders of Fcy receptorbearing T cells) involving an expansion of large granular lymphocyte/natural killer (LGL/NK) cells were investigated for the expression of LGL/NK-associated markers and for T0 gene rearrangement. All the cases selected were classified as T3' LPD on the basis of morphology, function, and phenotype of the circulating cells. 10 to 12 cases displayed clonai rearrangements of the TO locus and expression of the T3 antigen, whereas the 2 remaining cases displayed the germline configuration of the TO gene and no expression of the T3 antigen. T8, Mol, B73.1, and N901 antigens were variably expressed among both T/3+T3 + and T/3-T3-T3, LPD cases. We suggest that individual T3, LPD cases represent the clonal expansion of cells frozen at different stages of differentiation/activation within an individual hematopoietic LGL/NK lineage.
